title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Earnings Scheduled For May 12, 2022",20220512T085523,https://www.benzinga.com/news/earnings/22/05/27156592/earnings-scheduled-for-may-12-2022,ETON,0.017681,Neutral,-0.067728
"uniQure  ( QURE )  Up on Restructuring Plans, Workforce Reduction",20231006T153100,https://www.zacks.com/stock/news/2161746/uniqure-qure-up-on-restructuring-plans-workforce-reduction,ETON,0.153961,Neutral,0.079756
The Benchmark Company Announces Upcoming 12th Annual Discovery One-on-One Investor Conference,20231110T144754,https://www.benzinga.com/pressreleases/23/11/g35726156/the-benchmark-company-announces-upcoming-12th-annual-discovery-one-on-one-investor-conference,ETON,0.069094,Neutral,0.0
"Earnings Scheduled For March 16, 2022",20220316T092508,https://www.benzinga.com/news/earnings/22/03/26159067/earnings-scheduled-for-march-16-2022,ETON,0.045448,Neutral,-0.010464
"Congenital Adrenal Hyperplasia Treatment Drug Market to Exhibit Immense Growth During the Study Period  ( 2019-2032 ) , Predicts DelveInsight",20231221T220100,https://www.prnewswire.com/news-releases/congenital-adrenal-hyperplasia-treatment-drug-market-to-exhibit-immense-growth-during-the-study-period-20192032-predicts-delveinsight-302020741.html,ETON,0.055946,Neutral,-0.13806
